What we use
- FDA prescribing labels through DailyMed. Primary sources for approved indications, formulation limits, mechanisms, and safety. A DailyMed listing alone is not proof of FDA approval; we use the approved prescription-product labels identified on each page.
- MedlinePlus and NIH. Patient-friendly context and selected research summaries. Drug information on MedlinePlus may be authored by AHFS/ASHP; we link and paraphrase rather than reproduce its articles.
- Supporting medical literature. Used when a label does not answer a question, especially for off-label uses. NCBI-hosted clinical reviews are identified by their authors or publisher; hosting does not make them NIH recommendations.
Approved and off-label are different questions
Approval applies to a particular product, use, and population. Each explainer separates label indications from selected documented off-label uses. Evidence for an off-label use varies, and its inclusion is educational. Read the FDA explanation.
Historical ranking
The historical ten-row dataset follows ClinCalc DrugStats’ top ten for 2024, release 2026.08, derived from AHRQ’s 2024 MEPS Prescribed Medicines File (HC-254A). Verified September 20, 2026. This dataset does not select records for publication.
The metric is estimated outpatient prescription fills, including refills, for the U.S. civilian noninstitutionalized population. Brands and formulations are combined by ingredient. The year describes the prescribing data, not the year you are reading the page.
Survey estimates, not a census, live 2026 totals, or a measure of the best medication. Counts include refills and aggregate brands and formulations by ingredient. Inpatient administration and unreported over-the-counter purchases are outside this ranking. Estimates have sampling uncertainty; close ranks should not be overinterpreted.
| Rank | Medication | Estimated fills |
|---|---|---|
| 1 | Atorvastatin | 115,678,209 |
| 2 | Levothyroxine | 82,380,627 |
| 3 | Metformin | 82,288,616 |
| 4 | Amlodipine | 71,333,516 |
| 5 | Lisinopril | 66,676,852 |
| 6 | Albuterol | 61,972,757 |
| 7 | Losartan | 59,030,486 |
| 8 | Metoprolol | 58,193,752 |
| 9 | Rosuvastatin | 53,688,649 |
| 10 | Omeprazole | 49,784,460 |
Ranking adapted from ClinCalc DrugStats. Attribution: Sean P. Kane, ClinCalc DrugStats Database, version 2026.08. Adaptation: top-ten subset, explanatory labels, and rounded card counts. Ranking adaptation offered under CC BY-SA 4.0. Read ClinCalc’s methodology.
Clear limits, visible review status
Each explainer displays its actual review state. Source checking is distinct from qualified clinical review. Source access dates are recorded separately from clinical-review dates. These pages are educational and do not provide dosing, diagnosis, individual treatment selection, or a complete safety checklist.
Animations simplify a mechanism. Their movement, size, and timing do not represent real anatomy, dose, treatment speed, or an individual result. The written explanation remains available without animation.
Keeping the science current
Our editorial policy calls for a source review at least every three months, with earlier review when an important label or safety update is identified. A changed claim also requires review of the animation, script, captions, and SEO text that reuse it. Prescription rankings are reconsidered when a newer annual release becomes available.
Spotted an issue? See corrections & contact for how to report an issue. Do not include personal health information.
Educational use only
For education only. This site does not diagnose conditions, recommend a medication, or replace advice from your doctor or pharmacist. Do not start, stop, or change treatment based on an explainer. If you have a medical emergency, call 911.